Literature DB >> 9027873

Basic fibroblast growth factor is highly neuroprotective against seizure-induced long-term behavioural deficits.

Z Liu1, G L Holmes.   

Abstract

Basic fibroblast growth factor has been reported to protect neurons of various structures from excitotoxic damage. To study the effects of basic fibroblast growth factor on seizure-induced brain damage we infused the growth factor into the lateral ventricles of 35-day-old rats receiving convulsant dosages of kainic acid. Artificial cerebrospinal fluid or basic fibroblast growth factor at dosages of 0.5 ng/h or 2.5 ng/h was infused into the lateral ventricle continuously for seven days starting two days before and continuing for five days after the animals had kainic acid-induced status epilepticus. At age 80 days the animals underwent behavioural testing using the water maze, open field, and handling tests and at age 95 days were tested for seizure threshold using flurothyl inhalation. Neither artificial cerebrospinal fluid or basic fibroblast growth factor modified the latency or duration of the acute seizures following kainic acid. However, rats infused with 2.5 ng/h, but not 0.5 ng/h of basic fibroblast growth factor, had fewer spontaneous recurrent seizures, a higher seizure threshold, better performance in the handling, open field and water maze test, and less cell loss in the hippocampus when compared to rats receiving artificial cerebrospinal fluid or 0.5 ng/h of basic fibroblast growth factor. These results show that basic fibroblast growth factor has a dose-related neuroprotective effect against seizure-induced long-term behavioural deficits when administered by osmotic pump prior to seizure onset. This neuroprotective effect is not related to an anticonvulsant effect.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9027873     DOI: 10.1016/s0306-4522(96)00412-5

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  7 in total

Review 1.  Current Neurogenic and Neuroprotective Strategies to Prevent and Treat Neurodegenerative and Neuropsychiatric Disorders.

Authors:  I M Carvalho; P B Coelho; P C Costa; C S Marques; R S Oliveira; D C Ferreira
Journal:  Neuromolecular Med       Date:  2015-09-15       Impact factor: 3.843

2.  PEGylated rhFGF-2 conveys long-term neuroprotection and improves neuronal function in a rat model of Parkinson's disease.

Authors:  Guanghui Zhu; Ganping Chen; Lu Shi; Jenny Feng; Yan Wang; Chaohui Ye; Wenke Feng; Jianlou Niu; Zhifeng Huang
Journal:  Mol Neurobiol       Date:  2014-06-15       Impact factor: 5.590

Review 3.  Progress in neuroprotective strategies for preventing epilepsy.

Authors:  Munjal M Acharya; Bharathi Hattiangady; Ashok K Shetty
Journal:  Prog Neurobiol       Date:  2007-12-08       Impact factor: 11.685

4.  Prenatal choline supplementation attenuates neuropathological response to status epilepticus in the adult rat hippocampus.

Authors:  Sarah J E Wong-Goodrich; Tiffany J Mellott; Melissa J Glenn; Jan K Blusztajn; Christina L Williams
Journal:  Neurobiol Dis       Date:  2008-02-16       Impact factor: 5.996

Review 5.  Causes of CNS inflammation and potential targets for anticonvulsants.

Authors:  Mercé Falip; Xavier Salas-Puig; Carlos Cara
Journal:  CNS Drugs       Date:  2013-08       Impact factor: 5.749

6.  Antiepileptic drugs prevent changes induced by pilocarpine model of epilepsy in brain ecto-nucleotidases.

Authors:  Giana de Paula Cognato; Alessandra Nejar Bruno; Rosane Souza da Silva; Maurício Reis Bogo; João José Freitas Sarkis; Carla Denise Bonan
Journal:  Neurochem Res       Date:  2007-03-31       Impact factor: 4.414

7.  Implication of fibroblast growth factors in epileptogenesis-associated circuit rearrangements.

Authors:  Beatrice Paradiso; Silvia Zucchini; Michele Simonato
Journal:  Front Cell Neurosci       Date:  2013-09-13       Impact factor: 5.505

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.